What is the Actual Rate of Acute Skin Toxicity in Women Undergoing Adjuvant Radiation Therapy for Early Breast Cancer? Final Results of a Single Institution Phase II Study

被引：0
|
作者：
Niazi, T. [1 ,2 ]
Azoulay, M. [1 ]
Sultanem, K. [1 ]
Muanza, T. [1 ]
Bahoric, B. [1 ]
Faria, S. [1 ]
Vuong, T. [1 ,2 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.1703
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [31] Breast cancer and brain metastases in women under 45 years of age: Treatment results of radiation therapy at a single institution
    Ratosa, I.
    Znidaric, T.
    Marinko, T.
    Horvat, A. Gojkovic
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S115 - S115
  • [32] A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer: Updated Results
    Golden, E. B.
    Chhabra, A. M.
    Fenton-Kerimian, M. B.
    Novik, Y.
    Oratz, R.
    Speyer, J.
    Formenti, S. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E37 - E38
  • [33] Intraoperative radiation therapy delivered prior to lumpectomy for early-stage breast cancer: a single institution study
    Yu, Wei
    Lin, Zhi
    Ju, Zhong-Jian
    Li, Xi-Ru
    Zhang, Yan-Jun
    Kong, Qing-Long
    Gong, Han-Shun
    Wang, Jian-Dong
    Ma, Lin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (07): : 2249 - 2257
  • [34] Self-evaluation subjective toxicity according to the Common Toxicity Criteria in breast cancer patients undergoing adjuvant chemotherapy: final results of an Italian prospective study
    Montemurro, F.
    Mittica, G.
    Cagnazzo, C.
    Foresto, M.
    Longo, V.
    Berchialla, P.
    Solinas, G.
    Culotta, P.
    Martinella, R.
    Calori, A.
    Grasso, B.
    Volpone, C.
    Bertola, G.
    Parola, G.
    Del Torre, M.
    Giuliano, P. L.
    Aglietta, M.
    Ballari, A. M.
    ANNALS OF ONCOLOGY, 2015, 26 : 5 - 6
  • [35] Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments
    Scorsetti, Marta
    Alongi, Filippo
    Fogliata, Antonella
    Pentimalli, Sara
    Navarria, Pierina
    Lobefalo, Francesca
    Garcia-Etienne, Carlos
    Clivio, Alessandro
    Cozzi, Luca
    Mancosu, Pietro
    Nicolini, Giorgia
    Vanetti, Eugenio
    Eboli, Marco
    Rossetti, Carlo
    Rubino, Arianna
    Sagona, Andrea
    Arcangeli, Stefano
    Gatzemeier, Wolfgang
    Masci, Giovanna
    Torrisi, Rosalba
    Testori, Alberto
    Alloisio, Marco
    Santoro, Armando
    Tinterri, Corrado
    RADIATION ONCOLOGY, 2012, 7
  • [36] Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments
    Marta Scorsetti
    Filippo Alongi
    Antonella Fogliata
    Sara Pentimalli
    Pierina Navarria
    Francesca Lobefalo
    Carlos Garcia-Etienne
    Alessandro Clivio
    Luca Cozzi
    Pietro Mancosu
    Giorgia Nicolini
    Eugenio Vanetti
    Marco Eboli
    Carlo Rossetti
    Arianna Rubino
    Andrea Sagona
    Stefano Arcangeli
    Wolfgang Gatzemeier
    Giovanna Masci
    Rosalba Torrisi
    Alberto Testori
    Marco Alloisio
    Armando Santoro
    Corrado Tinterri
    Radiation Oncology, 7
  • [37] Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer:: final results of a multicenter phase II study
    Schmid, P
    Krocker, J
    Morack, G
    Heilmann, V
    Blohmer, JU
    Michniewicz, K
    Köhler, G
    Schaller-Kranz, T
    Possinger, K
    Elling, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (11) : 657 - 663
  • [38] Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
    P. Schmid
    J. Krocker
    G. Morack
    V. Heilmann
    J.-U. Blohmer
    K. Michniewicz
    G. Köhler
    T. Schaller-Kranz
    K. Possinger
    D. Elling
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 657 - 663
  • [39] Neoadjuvant trastuzumab and sequential chemotherapy with cisplatin, vinorelbine, and docetaxel for stage II-III breast cancer patients: Final results of a single institution phase II study.
    Carillio, Guido
    Aiello, Rosa Anna
    Chiarenza, Maurizio
    Ali, Marco
    Mazzola, Antonella
    Di Marco, Rosanna
    Taibi, Eleonora
    Fallica, Giuseppina
    Casella, Tiziana
    Zacchia, Alessandra
    Castiglione, Gaetano
    Caruso, Francesco
    Caruso, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Toxicity of dose-dense docetaxel followed by doxorubicin with cyclophosphamide as adjuvant therapy for breast cancer in a phase II study
    Lambert-Falls, Rosemary
    Modugno, Susan
    CLINICAL BREAST CANCER, 2007, 7 (09) : 697 - 704
12345